- Home
- PRME vs TRNS Comparison
PRME vs TRNS Comparison
Compare PRME & TRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PRME | TRNS |
|---|---|---|
| Founded | 2019 | 1964 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Electrical Products |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 601.1M | 661.7M |
| IPO Year | 2022 | N/A |
Fundamental Metrics
Financial Performance| Metric | PRME | TRNS |
|---|---|---|
| Price | $3.74 | $53.84 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 4 |
| Target Price | $9.31 | ★ $108.67 |
| AVG Volume (30 Days) | ★ 4.1M | 129.3K |
| Earning Date | 11-07-2025 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.22 |
| Revenue | $5,977,000.00 | ★ $302,584,000.00 |
| Revenue This Year | $179.58 | $20.17 |
| Revenue Next Year | N/A | $7.66 |
| P/E Ratio | ★ N/A | $44.99 |
| Revenue Growth | ★ 647.13 | 11.81 |
| 52 Week Low | $1.11 | $52.06 |
| 52 Week High | $6.94 | $111.45 |
Technical Indicators
Market Signals| Indicator | PRME | TRNS |
|---|---|---|
| Relative Strength Index (RSI) | 46.43 | 36.55 |
| Support Level | $3.26 | $53.19 |
| Resistance Level | $4.08 | $56.90 |
| Average True Range (ATR) | 0.32 | 2.79 |
| MACD | 0.07 | 0.60 |
| Stochastic Oscillator | 60.98 | 29.49 |
Price Performance
Historical ComparisonAbout PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.
About TRNS Transcat Inc.
Transcat Inc is involved in providing calibration and laboratory instrument services and the distribution of test, measurement, and control instrumentation. The product and services portfolio of the company consists of calibration instruments, dimensional measuring tools, Electrical test instruments, pressure measurement, and others. The firm has Service and Distribution operating segments. The company derives the majority of its revenues from the Service segment. The firm promotes and sells its products under brand names such as Extech, FLIR, Fluke, Keysight, Megger, and others.